Core Viewpoint - The announcement from 精优药业 (00858) details the resignation of Mr. 方林虎 as an independent non-executive director and chairman of the audit and remuneration committees, effective January 20, 2026, due to age and personal commitments. Ms. 杨晓蓉 is appointed as an independent non-executive director on the same date [1]. Group 1 - Mr. 方林虎 has served as an independent non-executive director since June 11, 2001 [1]. - The board has announced changes in the composition of the audit, remuneration, and nomination committees following Mr. 方's resignation [1]. - Ms. 金松 has been appointed as the new chair of the audit and remuneration committees, while Ms. 杨晓蓉 will join as a new member [1]. Group 2 - The nomination committee will also see changes, with Mr. 方 no longer serving as a member and Ms. 杨晓蓉 appointed as a new member [1].
精优药业(00858)：杨晓蓉获委任为独立非执行董事